Aller au contenu principal
Accès ouvert déclaré 2005 article

Effects of garlic powder tablet on blood sugar, plasma lipids and blood pressure in type 2 diabetic patients with hyperlipidemia.

3Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

Background: Diabetes, hypercholesterolemia and hypertension are three major risk factors that lead to the increased incidence of cardiovascular disease. Historically, there has been great interest in the role of garlic in reducing cardiovascular risk factors. In this study we evaluated effects of garlic tablet in type 2 diabetic patients with hyperlipidemia. Materials and method: A clinical trial (before and after) was performed in a group of 50 type 2 diabetic patients with hyperlipidemia (including 39 women, 11 men with serum cholesterol concentration greater than or equal to 220 mg/dl) to assess the effect of garlic powder tablet on blood glucose, lipid profiles and blood pressure. Each subject received tablets containing 300 mg of garlic powder (Garcin) 3 times per day for 6 weeks. Before and after the treatment, blood pressure, fasting blood glucose, glycated hemoglobin and lipid profiles were measured. 24 hr dietary recalls were used to evaluate nutritional status of the patients. Results: Our results indicate that 6 weeks supplementation with garlic powder tablets give rise to a significant decrease in total cholesterol (p Conclusion: 6 weeks treatment with garlic powder tablets significantly decreased total cholesterol, LDL-C, systolic blood pressure and increased HDL-C in type II diabetic patients with hyperlipidemia. Further studies are required to assess quality, efficacy and safety of this product.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

Aucun DOI disponible pour le contrôle Crossref.

Les sujets associés

Garlic and Onion StudiesDiabetes, Cardiovascular Risks, and LipoproteinsPharmacology and Obesity Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.